[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA42845A - RECOMBINATION LISTERIA VACCINE STRAINS AND METHODS OF USE OF SUCH STRAINS IN ANTI-CANCER IMMUNOTHERAPY - Google Patents

RECOMBINATION LISTERIA VACCINE STRAINS AND METHODS OF USE OF SUCH STRAINS IN ANTI-CANCER IMMUNOTHERAPY

Info

Publication number
MA42845A
MA42845A MA042845A MA42845A MA42845A MA 42845 A MA42845 A MA 42845A MA 042845 A MA042845 A MA 042845A MA 42845 A MA42845 A MA 42845A MA 42845 A MA42845 A MA 42845A
Authority
MA
Morocco
Prior art keywords
strains
recombination
methods
cancer immunotherapy
listeria vaccine
Prior art date
Application number
MA042845A
Other languages
French (fr)
Inventor
David J Mauro
Robert Petit
Original Assignee
Advaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advaxis Inc filed Critical Advaxis Inc
Publication of MA42845A publication Critical patent/MA42845A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA042845A 2015-09-17 2016-09-16 RECOMBINATION LISTERIA VACCINE STRAINS AND METHODS OF USE OF SUCH STRAINS IN ANTI-CANCER IMMUNOTHERAPY MA42845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562219961P 2015-09-17 2015-09-17

Publications (1)

Publication Number Publication Date
MA42845A true MA42845A (en) 2018-07-25

Family

ID=58289688

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042845A MA42845A (en) 2015-09-17 2016-09-16 RECOMBINATION LISTERIA VACCINE STRAINS AND METHODS OF USE OF SUCH STRAINS IN ANTI-CANCER IMMUNOTHERAPY

Country Status (10)

Country Link
EP (1) EP3349789A2 (en)
JP (1) JP2018527382A (en)
KR (1) KR20180043381A (en)
CN (1) CN108348591A (en)
AU (1) AU2016324170A1 (en)
CA (1) CA2998889A1 (en)
IL (1) IL258004A (en)
MA (1) MA42845A (en)
MX (1) MX2018003352A (en)
WO (1) WO2017049218A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9012141B2 (en) 2000-03-27 2015-04-21 Advaxis, Inc. Compositions and methods comprising KLK3 of FOLH1 antigen
WO2012125551A1 (en) 2011-03-11 2012-09-20 Advaxis Listeria-based adjuvants
JP2015511602A (en) 2012-03-12 2015-04-20 アドバクシス， インコーポレイテッド Inhibition of suppressor cell function after Listeria vaccine treatment
MX2016010791A (en) 2014-02-18 2017-04-27 Advaxis Inc Biomarker directed multi-target immunotherapy.
CN106459887A (en) 2014-04-24 2017-02-22 阿德瓦希斯公司 Recombinant listeria vaccine strains and methods of producing the same
MA41644A (en) 2015-03-03 2018-01-09 Advaxis Inc LISTERIA-BASED COMPOSITIONS INCLUDING A MINIGEN EXPRESSION SYSTEM CODING PEPTIDES, AND METHODS OF USE THEREOF
KR20190082850A (en) 2016-11-30 2019-07-10 어드박시스, 인크. Immunogen compositions targeting repeated cancer mutations and methods of using the same
SG11202002157TA (en) 2017-09-19 2020-04-29 Advaxis Inc Compositions and methods for lyophilization of bacteria or listeria strains
CN110499324A (en) * 2019-09-02 2019-11-26 中生康元生物科技(北京)有限公司 A method of for identifying the bacterial expression vector and screening and identification tumour neoantigen of tumour neoantigen

Also Published As

Publication number Publication date
IL258004A (en) 2018-05-31
EP3349789A2 (en) 2018-07-25
MX2018003352A (en) 2018-08-15
AU2016324170A1 (en) 2018-04-12
WO2017049218A2 (en) 2017-03-23
CN108348591A (en) 2018-07-31
CA2998889A1 (en) 2017-03-23
KR20180043381A (en) 2018-04-27
JP2018527382A (en) 2018-09-20

Similar Documents

Publication Publication Date Title
MA42845A (en) RECOMBINATION LISTERIA VACCINE STRAINS AND METHODS OF USE OF SUCH STRAINS IN ANTI-CANCER IMMUNOTHERAPY
HK1258041A1 (en) Immune cell compositions and methods of use
MA43124A (en) RECOMBINATED VACCINE STRAINS OF LISTERIA AND THEIR METHODS OF USE IN ANTI-CANCER IMMUNOTHERAPY
HK1252605A1 (en) Expression constructs and methods of genetically engineering methylotrophic yeast
HK1247636A1 (en) Rna guided eradication of human jc virus and other polyomaviruses
IL251624A0 (en) Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
IL248483A0 (en) Recombinant listeria vaccine strains and methods of producing the same
HUE043310T2 (en) Cot modulators and methods of use thereof
SG11201609118RA (en) Modified natural killer cells and uses thereof
IL249384A0 (en) Perfusion culturing methods and uses thereof
EP3092001A4 (en) Immunomodulatory compositions and methods of use thereof
HK1248531A1 (en) Immunomodulatory compositions and methods of use thereof
SG11201702116VA (en) Viral rna segments as immunomodulatory agents and vaccine components
PL3198008T3 (en) Pichinde virus reverse genetics system and methods of use
FR3025696B1 (en) FISH RESEARCH AND AGGREGATION EQUIPMENT
HK1254514A1 (en) Methods and compositions for enhancing immune response to vaccination
ZA201604870B (en) Recombinant microorganisms and methods of use thereof
HK1258731A1 (en) Hiv antibody compositions and methods of use
SG11201704942QA (en) Dengue virus vaccine compositions and methods of use thereof
SG11201606546VA (en) Antibodies to matrix metalloproteinase 9 and methods of use thereof
GB201421430D0 (en) Antibodies to Adam17 and uses thereof
GB2527909B (en) Improvements in and relating to imaging of the eye
GB201519421D0 (en) Methods and apparatuses relating to injection-moulded objects
HK1216006A1 (en) Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
GB201409548D0 (en) Methods and apparatuses relating to injection-moulded objects